APOE and Alzheimer disease: These findings suggest that in female AD patients, genetics, specifically APOE4 dosage, is a factor that drives psychosis symptoms in those with LB pathology, whereas the effect of APOE4 on psychosis is much more attenuated in male AD patients with LB pathology.